Should T-cell histiocyte rich B-cell lymphoma be classified as a morphological variant or a distinct clinicopathological entity?;Lymphome B riche en cellules T et histiocytes: Variante morphologique ou entité anatomo-clinique?

Hematologie

Volumn 9, Issue 3, 2003, Pages 191-199

  Ramuz, Olivier ^a   Bouabdallah, Reda ^a   Xerri, Luc ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

Classical Hodgkin lymphoma; Diffuse large B cell lymphoma; Nodular lymphocyte predominant Hodgkin lymphoma; Non Hodgkin lymphoma; T cell histiocyte rich B cell lymphoma

Indexed keywords

B CELL LYMPHOMA; B LYMPHOCYTE; CANCER GRADING; CANCER INVASION; CANCER RISK; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HEPATOMEGALY; HISTIOCYTE; HISTIOCYTIC LYMPHOMA; HODGKIN DISEASE; LYMPH NODE METASTASIS; MORPHOLOGY; NONHODGKIN LYMPHOMA; RISK FACTOR; SHORT SURVEY; SPLENOMEGALY; T CELL LYMPHOMA; T LYMPHOCYTE; TUMOR CELL;

EID: 0041317284     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (34)

1. Mirchandani I, Palutke M, Tabaczka P, Goldfarb S, Eisenberg L, Pak MS. B-cell lymphomas morphologically resembling T-cell lymphomas. Cancer 1985; 56: 1578-83.
2. Jaffe ES, Logo DL, Cossman J, Hsu SM, Arnold A, Korsmeyer SJ. Diffuse B-cell lymphomas with T-cell predominance in patients with follicular lymphoma or pseudo T cell lymphoma. Lab Invest 1984; 50: A17-28.
3. Arnold A, Cossman J, Bakhshi A, Jaffe ES, Waldmann TA, Korsmeyer SJ. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med 1983; 309: 1593-9.
4. Ramsay AD, Smith WJ, Isaacson PG. T-cell-rich B-cell lymphoma. Am J Surg Pathol 1988; 12: 433-43.
5. Macon WR, Williams ME, Greer JP, Stein RS, Collins RD, Cousar JB. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases. Am J Surg Pathol 1992; 16: 351-63.
6. Baddoura FK, Chan WC, Masih AS, Mitchell D, Sun NC, Weisenburger DD. T-cell-rich B-cell lymphoma. A clinicopathologic study of eight cases. Am J Clin Pathol 1995; 103: 65-75.
7. Osborne BM, Buller JJ, Pugh WC. The value of immunophenotyping on paraffin sections in the identification of T-cell rich B-cell large-cell lymphomas: lineage confirmed by JH rearrangement. Am J Surg Pathol 1990; 14: 933-8.
8. Ng CS, Chan JK, Hui PK, Lau WH. Large B-cell lymphomas with a high content of reactive T cells. Hum Pathol 1989; 20: 1145-54.
9. Krishnan J, Wollberg K, Frizzera G. T-cell-rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness. Am J Surg Pathol 1994; 18: 455-65.
10. Delabie J, Vandenberghe E, Kennes C, et al. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype. Am J Surg Pathol 1992; 16: 37-48.
11. Rodriguez J, Pugh WC, Cabanillas F. T-cell-rich B-cell lymphoma. Blood 1993; 82: 1586-9.
12. Greer JP, Macon WR, Lamar RE et al. T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients. J Clin Oncol 1995; 13: 1742-50.
13. Achten R, Verhoef G, Vanuytsel L, Wolf-Peeters C. T-cell/histiocyte-rich large B-cell lymphoma: distinct clinicopathologic entity. J Clin Oncol 2002; 20: 1269-77.
14. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. The World Health Organization classification of tumours of the hematopoietic and lymphoid tissues. Lyon: IARC Press, 2001: 171-4.
15. Rudiger T, Ott G, Ott MM, Muller-Deubert SM, Muller-Hermelink HK. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry. Am J Surg Pathol 1998; 22: 1184-91.
16. Achten R, Verhoef G, Vanuytsel L, Wolf-Peeters C. Histiocyterich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features. Histopathology 2002; 40: 31-45.
17. Bouabdallah R, Mounier N, Guettier C, et al. T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar responsiveness to chemotherapy: a matched-control analysis on 50 patients. J Clin Oncol 2003; 21: 1271-7.
18. Camilleri-Bröet S, Molina T, Audouin J, Tourneau AL, Diebold J. Morphological variability of tumour cells in T-cell-rich B-cell lymphoma. A histopathological study of 14 cases. Virchows Arch 1996; 429: 243-8.
19. Schmidt U, Leder LD. T-cell-rich B-cell lymphoma-a distinct clinicopathologic entity? Leuk Lymphomo 1996; 23: 17-24.
20. Fraga M, Sanchez-Verde L, Forteza J. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma. Histopathology 2002; 41: 216-29.
21. Lim MS, Bealy M, Sorbara L, et al. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells. Am J Surg Pathol 2002; 26: 1458-66.
22. Ohshima K, Masuda Y, Kikuchi M, et al. Monoclonal B cells and restricted oligoclonal T cells in T-cell-rich B-cell lymphoma. Pathol Res Pract 1994; 190: 15-24.
23. Stein H, Delsol G, Pileri S, et al. Nodular lymphocyte predominant Hodgkin lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. The World Health Organization classification of tumours of the hematopoietic and lymphoid tissues. Lyon: IARC Press, 2001: 240-3.
24. Rudiger T, Gascoyne RD, Jaffe ES, et al. Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol 2002; 13 Suppl 1: 44-51.
25. Pileri SA, Went P, Ascani S, Leoncini L, Falini B, Zinzani PL. Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification. Histopathology 2002; 41: 482-509.
26. Anagnostopoulos I, Hansmann ML, Franssila K, et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 2000; 96: 1889-99.
27. Stein H, Delsol G, Pileri S, et al. Classical Hodgkin lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. The World Health Organization classification of tumours of the hematopoietic and lymphoid tissues. Lyon: IARC Press, 2001: 244-53.
28. Brauninger A, Kuppers R, Spieker T, et al. Molecular analysis of single B cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells. Blood 1999; 93: 2679-87.
29. Macon WR, Cousar JB, Waldron JA Jr, Hsu SM. Interlieukin-4 may contribute to the abundant T-cell reaction and paucity of neoplastic B cells in T-cell-rich B-cell lymphomas. Am J Pathol 1992; 141: 1031-6.
30. Ponzio NM, Thorbecke GJ. Requirement for reverse immune surveillance for the growth of germinal center-derived murine lymphomas. Semin Cancer Biol 2000; 10: 331-40.
31. Thorbecke GJ, Ponzio NM. Reverse immune surveillance: on adaptive mechanism used by tumor cells to facilitate their survival and growth. Semin Cancer Biol 2000; 10: 327-30.
32. Chittal SM, Brousset P, Voigt JJ, Delsol G. Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease. Histopathology 1991; 19: 211-20.
33. Tilly H, Mounier N, Lederlin P, et al. Rondomised comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Études des Lymphomes de l'Adulte. J Clin Oncol 2000; 18: 1309-15.
34. Gisselbrecht C, Lepage E, Molina T, et al. Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma. J Clin Oncol 2002; 20: 2472-9.